INNO-GENE SA ZY -10 Cash Flow Quality Index
INNO-GENE SA ZY -10 cash flow quality index. INNO-GENE SA ZY -10 (WQ3) has a Cash Flow Quality Index of 0.05x as of December 2024. Operating cash flow of €147.00K is below net income of €2.91 Million, suggesting accrual-heavy earnings not yet converted to cash. See WQ3 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of INNO-GENE SA ZY -10 (2021–2024)
Cash flow quality index of INNO-GENE SA ZY -10 from 2021 to 2024. Historical Cash Flow Quality Index for INNO-GENE SA ZY -10 across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore WQ3 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
INNO-GENE SA ZY -10 Cash Flow Quality Index by Year (2021–2024)
INNO-GENE SA ZY -10 cash flow quality index by year from 2021 to 2024. Year-by-year earnings quality comparison for INNO-GENE SA ZY -10. For the full cash flow conversion analysis, see INNO-GENE SA ZY -10 operating cash flow efficiency.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -60.00x | €-1.13 Million | €18.85K | ▼ -171907.8% |
| 2022 | 0.03x | €11.00K | €315.00K | ▼ -96.9% |
| 2021 | 1.12x | €6.75 Million | €6.03 Million | — |